Navigation Links
FDA Not In Favor Of Legalizing Medical Marijuana

U.S. Food and Drug Administration (FDA) has categorically ruled out endorsing the use of marijuana for medical purposes.// This decision contradicts an Institute of Medicine report in 1999, which had said that marijuana, also called as pot, was useful in certain conditions like AIDS wasting, chemotherapy induced nausea and vomiting and cancer cachexia.

In a statement issued on Thursday, the FDA stated that "no sound scientific studies supported medical use of marijuana for treatment in the United States, and no animal or human data supported the safety or efficacy of marijuana for general medical use." This stand taken by the agency also pus question marks over states like Alaska, California, Colorado, Hawaii, Maine, Montana, Nevada, Oregon, Vermont and Washington that have legalized the use of marijuana as a medicine. The FDA is not in favor of legalizing the use of marijuana even if it is for medical purposes. "These measures are inconsistent with efforts to ensure that medications undergo the rigorous scientific scrutiny of the FDA approval process and are proven safe and effective.," it said. The FDA's decision means that the U.S. Drug Enforcement Agency (DEA) can take action against marijuana users even in states that have legalized it. Last year, a Supreme Court decision also found favor with authorities who arrested two California residents who were using the drug to relieve pain. One had brain cancer and the other severe back pain.
'"/>




Page: 1

Related medicine news :

1. “Cheeseburger Bill” Goes In Favor Of Fast Food Restaurans
2. Judgment In Favor Of Merck For Vioxx Drug
3. India - Favored Orthopedics Surgery Destination
4. UK MPs Vote In Favor Of Public Smoking Ban
5. Tsunami Unplugged: Natural Disasters Favor the Under-privileged
6. Cholesterol Drug Has a Favorable Effect on the Chronic Kidney Disease
7. Doctors Favor the Continued Publication of Free Drug Guide
8. Heart Attack Care Continues To Be Biased In Favor Of Men
9. Majority of Keralites Vote in Favor of HIV Certificate Before Marriage
10. Sub-Saharan Africans With HIV May Achieve Favorable Levels of ART Adherence
11. Highly Potent TB Strain Plays Favorites Targeting Specific Ethnic Groups
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma Research ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February 8, ...
(Date:2/12/2016)... ... 2016 , ... As a former television executive, owner Tal Rabinowitz knows how ... to decompress, Rabinowitz found herself drawn to a casual meditation class while working at ... life, implementing a 20-minute-per-day meditation practice with her team. After her tenure at NBC, ...
(Date:2/12/2016)... ... 12, 2016 , ... Itopia, a leader in cloud services ... Intelligence Platform (CIP) into Cielo®, a discovery, migration and cloud orchestration engine. This ... small and medium business (SMB) clients. , In recent years, BI ...
(Date:2/12/2016)... Arlington, TX (PRWEB) , ... February 12, 2016 , ... ... Worth, and other communities across eastern Texas, is launching a cooperative charity drive with ... and families. , Serving more than 50,000 individuals and families in need, the Tarrant ...
(Date:2/12/2016)... ... ... Donor Network West, the organ procurement organization that heals lives through organ ... Regional Medical Center. Under the collaboration, the first of its kind, specific organ donors ... certain time frame for donor families for the recovery of organs. , Organ ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... -- Eli Lilly and Company (NYSE: LLY ) today announced ... vitamin regimen patent would not presently be infringed by Actavis ... , Italy and Spain ... dextrose solution.  --> --> ... held that Lilly,s patent would be indirectly infringed by Actavis ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary ... and future adoption patterns on the usage of liquid ... the following: - Timeframe of liquid biopsy ... ctDNA, cfDNA and Evs—by organization type - Sample inflow ... types: blood, saliva, stool, serum, and so on. - ...
Breaking Medicine Technology: